Nova Patents
AT110083T

Use of glucagone-like-peptide 1 (GLP-1) derivatives for the preparation of pharmaceutical compositions

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

22 members in 7 offices

This recordMember, by publication datePriority claim

Priority claims1

Priority claims
DocumentOfficeKindDate
85992886United States of AmericaA

Members22

Family members, oldest first
DocumentOfficeKind
WO8706941A1World Intellectual Property Organization (WIPO)A1
EP0305387A1European Patent Office (EPO)A1
JPH01502746AJapanA
EP0305387A4European Patent Office (EPO)A4
US5118666AUnited States of AmericaA
US5120712AUnited States of AmericaA
EP0587255A1European Patent Office (EPO)A1
EP0305387B1European Patent Office (EPO)B1
AT110083TThis recordAustriaT
DE3750402D1GermanyD1
DE3750402T2GermanyT2
EP0305387B2European Patent Office (EPO)B2
JP2583257B2JapanB2
US5614492AUnited States of AmericaA
DE3750402T3GermanyT3
US5958909AUnited States of AmericaA
US6162907AUnited States of AmericaA
CA1341320CCanadaC
EP1498425A1European Patent Office (EPO)A1
US6849708B1United States of AmericaB1
US2005119178A1United States of AmericaA1
US7138486B2United States of AmericaB2